Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

Deborah J. Wexler MD, MSc Associate Editor

Kathleen M. Dungan MD, MPH Advisory Board

Richard E. Pratley MD Associate Editor

See All Experts

featured

Published in Diabetes and

Journal Scan / Research · December 06, 2023

Semaglutide for Weight Loss in Patients With Severe Obesity With or Without a History of Bariatric Surgery

Obesity

Save Recommend

Sign in to PracticeUpdate

Only registered members have full access to PracticeUpdate content.

Not a member?

Join for free

Disclosure statements are available on the authors' profiles:

Carolina Gonzalez-Lopez MD

Brian Wojeck MD, MPH

Obesity

Semaglutide 2.4 mg/wk for weight loss in patients with severe obesity and with or without a history of bariatric surgery

Obesity 2023 Nov 05;[EPub Ahead of Print], JB Bonnet, S Tournayre, J Anitcheou, M Faivre, C Boegner, A Jalek, D Jullien, V Attalin, J Myzia, L Marty, Y Kemba, D Nocca, A Sultan, A Avignon

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Obesity, Metabolic Syndrome, and Prediabetes

Semaglutide for Weight Loss in Patients With Severe Obesity With or Without a History of Bariatric Surgery

Additional Info

Semaglutide 2.4 mg/wk for weight loss in patients with severe obesity and with or without a history of bariatric surgery

Further Reading

Real-World Effectiveness of Oral Semaglutide in Adults and Older Individuals With Type 2 Diabetes

Effect of Combined Use of SGLT2 Inhibitors and Pioglitazone on the Risk of MASH in Individuals With Type 2 Diabetes

Trends in the Incidence of Young Adult–Onset Diabetes by Diabetes Type

Implications of Continuous Ketone Monitoring in Clinical Practice

Characterizing the Effects of Using GLP-1 Receptor–Based Agonists on Body Composition

The SEAD Program Improved Clinical Outcomes in Underserved Young Adults With Type 1 Diabetes

Predicting Hypoglycemia and Hyperglycemia Risks During and After Physical Activity in Adolescents With Type 1 Diabetes

Family History of Diabetes and Clinical Characteristics in Children at the Diagnosis of Type 1 Diabetes

Effect of Sarcopenic Obesity on the Progression of Glycaemic Status in Middle-Aged and Older Adults Without Diabetes

Association of Early Post-Transplantation Hyperglycaemia and Diabetes Mellitus on Outcomes Following Heart Transplantation

Associations of Diabetes and Prediabetes With Mortality and Life Expectancy in Chinese Individuals

Recently Updated